医学
免疫系统
抗病毒药物
大流行
药品
免疫学
重症监护医学
病毒
2019年冠状病毒病(COVID-19)
药理学
疾病
传染病(医学专业)
内科学
作者
Mony Thakur,Mona Singh,Sandeep Kumar,Ved Prakash Dwivedi,Tikam Chand Dakal,Vinod Kumar Yadav
出处
期刊:ACS pharmacology & translational science
[American Chemical Society]
日期:2023-10-10
卷期号:6 (11): 1600-1615
标识
DOI:10.1021/acsptsci.3c00178
摘要
In the present era of the COVID-19 pandemic, viral infections remain a major cause of morbidity and mortality worldwide. In this day and age, viral infections are rampant and spreading rapidly. Among the most aggressive viral infections are ebola, AIDS (acquired immunodeficiency syndrome), influenza, and SARS (severe acute respiratory syndrome). Even though there are few treatment options for viral diseases, most of the antiviral therapies are ineffective owing to frequent mutations, the development of more aggressive strains, drug resistance, and possible side effects. Traditionally, herbal remedies have been used by healers, including for dietary and medicinal purposes. Many clinical and scientific studies have demonstrated the therapeutic potential of plant-derived natural compounds. Because of unsafe practices like blood transfusions and organ transplants from infected patients, medical supply contamination. Our antiviral therapies cannot achieve sterile immunity, and we have yet to find a cure for these pernicious infections. Herbs have been shown to improve therapeutic efficacy against a wide variety of viral diseases because of their high concentration of immunomodulatory phytochemicals (both immunoinhibitory and anti-inflammatory). Combined with biotechnology, this folk medicine system can lead to the development of novel antiviral drugs and therapies. In this Review, we will summarize some selected bioactive compounds with probable mechanisms of their antiviral actions, focusing on the immunological axis of these compounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI